Which company could become the Chinese Pfizer? Here are analysts’ top picks
AdvertisementChina’s private sectorBusinessChina Business Which company could become the Chinese Pfizer? Here are analysts’ top picks A boom in outlicensing…
China’s Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials
AdvertisementBiomedicine: CompaniesBusinessChina Business China’s Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials The agreement covers eight…